Lower riskMedical device recall · FDA · Published March 9, 2022
BD Synapsys Microbiology Software Version 4.10 Overwrites Custom Antibiotic Codes
Becton Dickinson recalls BD Synapsys Microbiology Informatics Software Version 4.10 due to custom antibiotic codes being overwritten during updates. Affected users should contact for remedy.
When updating BD Kiestra customers to BD Synapsys version 4.10, the custom antibiotic codes set by the customer are overwritten with the BD default antibiotic codes.
“BD Synapsys Microbiology Software Version 4.10 Overwrites Custom Antibiotic Codes.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/60963-bd-synapsys-microbiology-software-version-4-10-overwrites-custom-antibiotic. Based on FDA recall #Z-1018-2022 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1018-2022%22&limit=1).
The FDA announced on March 9, 2022, that Becton Dickinson & Co. voluntarily recalled the BD Synapsys Microbiology Informatics Solution, Catalog Number 444150, Software Version 4.10. The recall addresses a hazard where updating BD Kiestra customers overwrites custom antibiotic codes with BD default codes.
According to the FDA, when updating BD Kiestra customers to BD Synapsys version 4.10, the custom antibiotic codes set by the customer are overwritten with the BD default antibiotic codes.
Context
GovInfoNow's records show Becton Dickinson & Co. has 43 other recalls on record since June 1, 2017. Other recent recalls include the BD GasPak EZ Campy Pouch System Recall dated April 7, 2026, and the BD Kiestra Isolate Suspension Cuvette Array recall dated October 23, 2025.
How to tell if you have this one
Check for software version 4.10 on your BD Synapsys system. The UDI is 00382904441500 and serial numbers include SL00530, SL00515, and others listed in the recall.
Brand
Becton Dickinson
Category
Medical device
Based on the official FDA remedy
What to do — step by step
Check Software Version
Verify your BD Synapsys software version by checking the system settings or documentation.
Contact Manufacturer
Reach out to Becton Dickinson for guidance on updating or reverting to a previous version.
Where it went and when
Where it was distributed
Distributed nationwide and abroad; the notice names 7 states.
Named in the notice
Covered by “nationwide”
Not listed
FDA distribution: “Worldwide distribution US Nationwide distribution in the states of CA, IL, MI, NY, OH, SC, and TN. The countries of Austria, France, Germany, Netherlands, Sweden.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Named in the notice: California, Illinois, Michigan, New York, Ohio, South Carolina, Tennessee.
Recall timeline
FDA terminated this recall 22 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-1018-2022 (March 9, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1018-2022 to see it in context.
Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.